Chandigarh Herald

Biomaterials Market SWOT Analysis, by Manufacturers, Production, Sales, Revenue, Price and Investment Opportunities to 2025

 Breaking News
  • No posts were found

Biomaterials Market SWOT Analysis, by Manufacturers, Production, Sales, Revenue, Price and Investment Opportunities to 2025

April 26
23:50 2023
Biomaterials Market SWOT Analysis, by Manufacturers, Production, Sales, Revenue, Price and Investment Opportunities to 2025
Browse 333 market data Tables and 47 Figures spread through 298 Pages and in-depth TOC on “Biomaterials Market – Global Forecast to 2025
The primary drivers of this growth are the increasing demand for medical device and implant products, the rising aging population, and the increasing government support for research and development in the field of biomaterials

The report “Biomaterials Market Size, Growth by Type of Materials (Metallic, Ceramic, Polymers, Natural), Application (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Neurological disorders, Tissue Engineering, Ophthalmology) – Global Forecast to 2025“, is projected to reach USD 47.5 billion by 2025, at a CAGR of 6.0%

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=393

Biomaterials are an increasingly important area of research and development in the medical industry, offering improved safety and efficacy in many medical procedures. As the use of biomaterials increases, so too does the demand for these materials, resulting in a growing global biomaterials market.

In terms of type, the global biomaterials market is divided into natural biomaterials, synthetic biomaterials, and composite biomaterials. Natural biomaterials are derived from plants, animals, and other natural sources, while synthetic biomaterials are artificially created from polymers, ceramics, and metals. Composite biomaterials are a combination of natural and synthetic biomaterials.

The biomaterials market is further segmented by application, with biomedical implants, tissue engineering, drug delivery systems, and wound care products being the primary applications. The biomedical implants segment is expected to be the largest segment, driven by the increasing demand for joint replacements and dental implants.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=393

Key Market Players

The global biomaterials market is highly consolidated. Key players in the biomaterials market include BASF SE (Germany), Covestro AG (Germany), Celanese Corporation (US), Corbion (Netherlands), Royal DSM (Netherlands), Evonik Industries (Germany), Carpenter Technology Corporation (US), Berkeley Advanced Biomaterials (US), Cam Bioceramics B.V. (Netherlands), CoorsTek Inc. (US), CeramTec (Germany), and Gelita AG (Germany). Acquisitions and product launches are the key growth strategies undertaken by these companies to maintain their positions in the market.

BASF SE (Germany)

BASF is one of the leading players in the biomaterials market. The company focuses on various organic and inorganic means to enhance its presence in the market. The company also focuses on expanding its global production capacity and invests ~USD 450 million per year in optimizing its plants. Additionally, BASF aims at developing its portfolio with innovations and investments.

Covestro AG (Germany)

Covestro is another key player in the biomaterials market. The company offers a wide range of biomaterials for the healthcare industry. The company invests majorly in the maintenance and expansion of its production facilities. Additionally, in the last three years, the company has mainly focused on product innovations and has launched several innovative products to sustain its leading position in the biomaterials market.

Celanese Coorporation (US)

Celanese is one of the key players in the biomaterials market. The company has a wide range of product offerings, including biomaterials for medical devices and drug delivery systems. A comprehensive range of products, high focus on R&D, and strong geographical presence are the key factors contributing to the leading position of the company in this market. the company added a new GUR ultra-high molecular weight polyethylene (UHMW-PE) production line at its Texas, US, manufacturing facility to support the significant growth in its high-value GUR Engineered Materials portfolio. With its strong product portfolio & robust geographic presence, the company is likely to maintain its leading position in this market.

Asia Pacific is the fastest-growing region of the biomaterials market.

The biomaterials market is segmented into North America, Europe, the Asia Pacific (APAC) and Rest of the World (RoW). Asia Pacific is the fastest-growing region of the biomaterials market. This regional segment offers significant growth opportunities to key players operating in the biomaterials market owing to the supportive regulatory framework to improve healthcare infrastructure, high production of titanium metal and its products in China, Japan’s growing healthcare industry, increasing geriatric population, rising cases of hip & knee replacement procedures, rising number of cosmetic and plastic surgeries in India, lucrative medical devices industry, and favorable tax policies in China.

Recent Developments

  • Royal DSM (Netherlands) and ProMed Pharma (US) partnered for the development of novel sustained release drug delivery solutions in the polymeric drug delivery area.
  • Covestro AG (Germany) signed an MoU with a group of ten companies and two research organizations with an aim to build a Composite Application Center (CAC) in Singapore. This was aimed to develop end-to-end solutions for advanced composites, such as thermoplastic materials.
  • Celanese Corporation (US) announced an expansion of its production facility of thermoplastic co-polyesters. This expansion is expected to support the demand of its global engineered

Make an Enquire to Buy this Report @  https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=393

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/biomaterials-393.html

Related Articles